$2.43T
Total marketcap
$76.1B
Total volume
BTC 50.63%     ETH 14.93%
Dominance

Nanobac Pharmaceuticals, Incorporated NNBP Stock

0 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
1.25K USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
10 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Nanobac Pharmaceuticals, Incorporated Price Chart

Nanobac Pharmaceuticals, Incorporated NNBP Financial and Trading Overview

Nanobac Pharmaceuticals, Incorporated stock price 0.0000 USD
Previous Close 1.0E-6 USD
Open 1.0E-6 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 1.0E-6 - 1.0E-6 USD
52 Week Range 1.0E-6 - 0.0001 USD
Volume 1K USD
Avg. Volume 0 USD
Market Cap 1.25K USD
Beta (5Y Monthly) -31.168308
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (2.18%)
Ex-Dividend Date N/A
1y Target Est N/A

NNBP Valuation Measures

Enterprise Value 4.12M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.070767835
Price/Book (mrq) N/A
Enterprise Value/Revenue 233.714
Enterprise Value/EBITDA -1.036

Trading Information

Nanobac Pharmaceuticals, Incorporated Stock Price History

Beta (5Y Monthly) -31.168308
52-Week Change 900.00%
S&P500 52-Week Change 20.43%
52 Week High 0.0001 USD
52 Week Low 1.0E-6 USD
50-Day Moving Average 0.0001 USD
200-Day Moving Average 0.0001 USD

NNBP Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 0
Float N/A
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:4

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2007
Most Recent Quarter (mrq) December 31, 2007
Next Fiscal Year End December 31, 2008

Profitability

Profit Margin 0%
Operating Margin (ttm) -25162.085%
Gross Margin 17.60%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -36.83%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 17.62K USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) 86.59%
Gross Profit (ttm) 3.1K USD
EBITDA -3973509 USD
Net Income Avi to Common (ttm) -6576111 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.93K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 4.12M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.005
Book Value Per Share (mrq) -0.009

Cash Flow Statement

Operating Cash Flow (ttm) -910886 USD
Levered Free Cash Flow (ttm) 1.03M USD

Profile of Nanobac Pharmaceuticals, Incorporated

Country United States
State FL
City Tampa
Address 3000 Bayport Drive
ZIP 33607
Phone 813-865-1125
Website N/A
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 1

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.

Q&A For Nanobac Pharmaceuticals, Incorporated Stock

What is a current NNBP stock price?

Nanobac Pharmaceuticals, Incorporated NNBP stock price today per share is 0.0000 USD.

How to purchase Nanobac Pharmaceuticals, Incorporated stock?

You can buy NNBP shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Nanobac Pharmaceuticals, Incorporated?

The stock symbol or ticker of Nanobac Pharmaceuticals, Incorporated is NNBP.

Which industry does the Nanobac Pharmaceuticals, Incorporated company belong to?

The Nanobac Pharmaceuticals, Incorporated industry is Biotechnology.

How many shares does Nanobac Pharmaceuticals, Incorporated have in circulation?

The max supply of Nanobac Pharmaceuticals, Incorporated shares is 0.

What is Nanobac Pharmaceuticals, Incorporated Price to Earnings Ratio (PE Ratio)?

Nanobac Pharmaceuticals, Incorporated PE Ratio is now.

What was Nanobac Pharmaceuticals, Incorporated earnings per share over the trailing 12 months (TTM)?

Nanobac Pharmaceuticals, Incorporated EPS is 0 USD over the trailing 12 months.

Which sector does the Nanobac Pharmaceuticals, Incorporated company belong to?

The Nanobac Pharmaceuticals, Incorporated sector is Healthcare.